Jean Pierre Kerckaert

Author

Inserm

Also Known As

J P Kerckaert, J-P Kerckaert, J. P. Kerckaert, J.-P. Kerckaert, J.P. Kerckaert, Jean Pierre Kerckaert

Publications

1.6K

Citations

H-Index

Concepts

All Affiliations

Inserm Institut pour la Recherche sur le Cancer de Lille Université de Lille Centre Henri Becquerel Centre Virchow-Villermé

About

Jean Pierre Kerckaert is an author at Inserm specializing in medicine, cell biology, and gene expression.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	9	9	875
2	Cell Biology	5	5	335
3	Natural Sciences	3	3	607
4	Health Sciences	1	1	13
5	Endocrinology	1	1	15

Jean Pierre Kerckaert

Publications

1.6K

Citations

H-Index

Page 1

	Year	Citations
Splicing with inverted order of exons occurs proximal to large introns. Claude Cocquerelle, Pierre Daubersies, Marie-Ange Majérus, The EMBO Journal Sequence MotifExons OccursGeneticsNatural SciencesRna Splicing	1992	317
High incidence of biallelic point mutations in the Runt domain of the AML1/PEBP2αB gene in Mo acute myeloid leukemia and in myeloid malignancies with acquired trisomy 21 Claude Preudhomme, Delphine Warot-Loze, Christophe Roumier, Blood	2000	254
<i>MEF2C</i> haploinsufficiency caused by either microdeletion of the 5q14.3 region or mutation is responsible for severe mental retardation with stereotypic movements, epilepsy and/or cerebral malformations Nathalie Le Meur, Muriel Holder‐Espinasse, Sylvie Jaillard, Journal of Medical Genetics	2009	220
The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain. Clotilde Deweindt, Olivier Albagli, Florent Bernardin, PubMed Transcriptional RegulationSystems BiologyBtb/poz RegionCell RegulationAutonomous Repressing Domain	1995	146
A novel modulator domain of Ets transcription factors. Christine Wasylyk, Jean Pierre Kerckaert, Bohdan Wasylyk Genes & Development Molecular RegulationGeneticsGenomic MechanismMolecular BiologyTranscriptional Regulation	1992	144
Mutations of the P53 gene in acute myeloid leukaemia Pierre Fenaux, Claude Preudhomme, I. Quiquandon, British Journal of Haematology Hematological MalignancyPoint MutationsP53 GeneGeneticsMixed-phenotype Acute Leukemia	1992	118
Detection of minimal residual disease in chronic myeloid leukemia patients after bone marrow transplantation by polymerase chain reaction. Marie Hélène Delfau, Jean Pierre Kerckaert, M. Collyn d'Hooghe, PubMed	1990	93
Rare occurrence of P53 gene mutations in multiple myeloma Claude Preudhomme, Thierry Façon, Marc Zandecki, British Journal of Haematology	1992	76
Recurrent genomic aberrations combined with deletions of various tumour suppressor genes may deregulate the G1/S transition in CD4+CD56+ haematodermic neoplasms and contribute to the aggressiveness of the disease Fabrice Jardin, Mary Callanan, Dominique Penther, Leukemia Cd4+cd56+ Haematodermic NeoplasmsImmunologyPathologyRecurrent Genomic AberrationsTumor Suppressor	2009	64
Multiple Domains Participate in Distance-Independent LAZ3/BCL6-Mediated Transcriptional Repression Olivier Albagli, Philippe Dhordain, Florence Bernardin, Biochemical and Biophysical Research Communications Transcriptional RegulationCell RegulationGene ExpressionGene RegulationTranscription Factors	1996	43

Page 1